Health ❯Cancer

Clinical Trials

NIAGARA Trial Patient Stratification Translational Research

UCSF Researchers Target Variant Bladder Cancer With CAR-T Therapy

Engineered T cells homed in on TM4SF1-expressing tumors in mice, laying the groundwork for upcoming clinical trials.

Immunotherapy Drug Significantly Improves Survival Rates in Bladder Cancer